Elias Zerhouni and Andy Plump discuss the future of multispecific biologics

<p>Interviewed by Andy Plump, President of R&amp;D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind them. They also discuss the differences between pharma and biotech, keys to being an effective R&amp;D leader, and advice for both young and experienced people in their careers.</p>